BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36294938)

  • 1. Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4-
    Jovanović Stojanov S; Kostić A; Ljujić M; Lupšić E; Schenone S; Pešić M; Dinić J
    Life (Basel); 2022 Sep; 12(10):. PubMed ID: 36294938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazolo[3,4-
    Kostić A; Jovanović Stojanov S; Podolski-Renić A; Nešović M; Dragoj M; Nikolić I; Tasić G; Schenone S; Pešić M; Dinić J
    Brain Sci; 2021 Jun; 11(7):. PubMed ID: 34209342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In Vivo.
    Nešović M; Divac Rankov A; Podolski-Renić A; Nikolić I; Tasić G; Mancini A; Schenone S; Pešić M; Dinić J
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line.
    Cammarata FP; Torrisi F; Forte GI; Minafra L; Bravatà V; Pisciotta P; Savoca G; Calvaruso M; Petringa G; Cirrone GAP; Fallacara AL; Maccari L; Botta M; Schenone S; Parenti R; Cuttone G; Russo G
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells.
    Monteleone L; Marengo B; Musumeci F; Grossi G; Carbone A; Valenti GE; Domenicotti C; Schenone S
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-
    Fallacara AL; Zamperini C; Podolski-Renić A; Dinić J; Stanković T; Stepanović M; Mancini A; Rango E; Iovenitti G; Molinari A; Bugli F; Sanguinetti M; Torelli R; Martini M; Maccari L; Valoti M; Dreassi E; Botta M; Pešić M; Schenone S
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31248184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment.
    Vagaggini C; Petroni D; D'Agostino I; Poggialini F; Cavallini C; Cianciusi A; Salis A; D'Antona L; Francesconi V; Manetti F; Damonte G; Musumeci F; Menichetti L; Dreassi E; Carbone A; Schenone S
    Drug Dev Res; 2024 Feb; 85(1):e22158. PubMed ID: 38349262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pyrazolo[3,4-
    Rango E; Pastorino F; Brignole C; Mancini A; Poggialini F; Di Maria S; Zamperini C; Iovenitti G; Fallacara AL; Sabetta S; Clementi L; Valoti M; Schenone S; Angelucci A; Ponzoni M; Dreassi E; Botta M
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of SRC Signaling Is Effective in Reducing Synergy between Glioblastoma and Stromal Cells.
    Calgani A; Vignaroli G; Zamperini C; Coniglio F; Festuccia C; Di Cesare E; Gravina GL; Mattei C; Vitale F; Schenone S; Botta M; Angelucci A
    Mol Cancer Ther; 2016 Jul; 15(7):1535-44. PubMed ID: 27196762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AuNP Pyrazolo[3,4-
    Molinari A; Iovenitti G; Mancini A; Gravina GL; Chebbi M; Caruana M; Vignaroli G; Orofino F; Rango E; Angelucci A; Dreassi E; Schenone S; Botta M
    ACS Med Chem Lett; 2020 May; 11(5):664-670. PubMed ID: 32435368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRC Tyrosine Kinase Inhibitor and X-rays Combined Effect on Glioblastoma Cell Lines.
    Torrisi F; Minafra L; Cammarata FP; Savoca G; Calvaruso M; Vicario N; Maccari L; Pérès EA; Özçelik H; Bernaudin M; Botta L; Russo G; Parenti R; Valable S
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of autophagy sensitizes multidrug resistant cells towards Src tyrosine kinase specific inhibitor PP2.
    Ahn JH; Lee M
    Cancer Lett; 2011 Nov; 310(2):188-97. PubMed ID: 21775053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Pyrazolo[3,4-
    Greco C; Taresco V; Pearce AK; Vasey CE; Smith S; Rahman R; Alexander C; Cavanagh RJ; Musumeci F; Schenone S
    ACS Med Chem Lett; 2020 May; 11(5):657-663. PubMed ID: 32435367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma.
    Omoruyi SI; Ekpo OE; Semenya DM; Jardine A; Prince S
    Apoptosis; 2020 Apr; 25(3-4):261-274. PubMed ID: 32036474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma.
    Wang J; Liu X; Hong Y; Wang S; Chen P; Gu A; Guo X; Zhao P
    J Exp Clin Cancer Res; 2017 Jul; 36(1):96. PubMed ID: 28716053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells.
    Kang M; Lee KH; Lee HS; Jeong CW; Kwak C; Kim HH; Ku JH
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28165387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells.
    Zhang X; Li W; Wang C; Leng X; Lian S; Feng J; Li J; Wang H
    Mol Cell Biochem; 2014 Jan; 385(1-2):265-75. PubMed ID: 24104452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors.
    Rothschild SI; Gautschi O; Batliner J; Gugger M; Fey MF; Tschan MP
    Lung Cancer; 2017 May; 107():73-83. PubMed ID: 27372519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDR1 (discoidin domain receptor tyrosine kinase 1) drives glioblastoma therapy resistance by modulating autophagy.
    Vehlow A; Cordes N
    Autophagy; 2019 Aug; 15(8):1487-1488. PubMed ID: 31117874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells.
    Ciarcia R; Damiano S; Montagnaro S; Pagnini U; Ruocco A; Caparrotti G; d'Angelo D; Boffo S; Morales F; Rizzolio F; Florio S; Giordano A
    Cell Cycle; 2013 Sep; 12(17):2839-48. PubMed ID: 23966159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.